2000, Number 2
<< Back Next >>
Arch Cardiol Mex 2000; 70 (2)
Deletion within chromosome 22 (22Q11.2). Etiology of conotruncal heart malformations
Buendía HA, Calderón-Colmenero J, Aizpuru E, Attie CL
Language: Spanish
References: 26
Page: 148-153
PDF size: 159.46 Kb.
ABSTRACT
Important advances in the diagnosis and treatment of congenital heart disease (CHD) have been made in the past 50 years. Nowadays echocardiogram plays an important role in the diagnosis. This procedure is able to identify a wide range of malformations. Cardiac catheterization is mainly a therapeutic tool, surgery is now performed much earlier because CHDS are diagnosed sometimes before birth or very early in life.
All this advances in the diagnosis and treatment of this group of patients, allows them not only a better quality of life but also the possibility of reaching adulthood and having children. The study of the etiology of CHD is a field that has not evolved as fast as the assessment and treatment. Nowadays we have a larger population of adults with CHD.
The discovery of a microdeletion of chromosome 22 q11.2 associated with conotruncal cardiac defects, proves a common etiology for clinical phenotypes and conotruncal malformations.
In order to identify, which of these patients share the same etiology and presented with this syndrome, we collected a group that shared not only heart defects of the conotruncal type but also specific phenotypic alterations such as broad nasal bridge, nasal dimple, high palate, and digitalization of the first finger among others. The first two patients studied with FISH technique were positive to monosomy of a locus on chromosome 22. Those patients with CHD of conotruncal type should undergo microdeletion testing so genetic counseling can be offered as well as appropriate treatment in areas such as cardiology and developmental psychology.
REFERENCES
Attie F, Zabal C, Buendía A: Cardiología Pediátrica. Diagnóstico y Tratamiento. México: 1ª Ed. Médica Panamericana, 1993; 26.
Noonan J: Association of Congenital Heart Disease with Syndromes or other defect. Pediatric Clinics of North America 1978; 24: 797-816.
Payne RM, Johnson MC, Grant JW, Strauss AW: Toward a Molecular Understanding of Congenital Heart Disease. Circulation 1995; 91: 494-504.
Moerman P, Durmoulin M, Lauweryns S, Vander Hauwaerth LG: Interrupted right aortic in DiGeorge Syndrome. Br Heart J 1987; 58: 274-278.
Buendía A, Zabal C, Attie F, Vazquez-Antona C, Aizpuru VE, Attie CL: ¿A new syndrome involving the heart? Abstracts of World Congress of Pediatric Cardiology and Pediatric Cardiac Surgery. Paris 1993. Cardiology in the Young 1993; 3(S1): 83.
Goldberg R, Mtzkin B, Marion R Scambler PJ, Shprintzen R: Velocardiofacial syndrome, a review of 120 patients. Am J Med Genet 1993; 45: 313-319
Scambler PJ, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R: Velocardiofacial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992; 339: 1138-1139.
Burn J, Takao A, Wilson D, Cross I, Momma K, Wadey R: Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J Med Genet 1993; 30: 822-24.
Driscoll DA, Bufard ML, Emanuel BS: A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet 1992; 50: 924-33.
Iserin L, deLonlay P, Viot G, Sidi D, Kachaner J, Munnich A: Prevalence of the microdeletion 22q11 in newborn infants with congenital conotruncal cardiac anomalies. Eur J Pediatr 1998; 157(11): 881-4.
Hofbeck M, Ruach A, Buheitel G, Leipold G, von der Emde J, Pfeiffer R: Monosomy 22q11 in patients with pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries. Heart 1998; 79(2): 180-5.
Fokstuen S, Arbenz U, Artan S: 22q11 deletions in a series of patients with non-selective congenital heart defects : incidence, type of defects parental origin. Clin Genet 1998; 53(1): 63-69.
Carey AH, Kelly D, Halford S, Wadey R, Wilson D, Goodship J, Burn J, Paul T: Molecular Genetic Study of the Frequency of Monosomy 22q11 in DiGeorge Syndrome. Am J Hum Genet 1992; 51: 964-970.
Burn J, Takao A, Wilson D, Cross I, Momma K, Wadey R, Scrambler P: Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J Med Genet 1993; 30: 822-824.
Patiño-Bahena E.J, Rylaarsdam M, Buendía A, Leis T. Attie F: Primer estudio interinstitucional de Ecocardiografía fetal en pacientes con riesgo de cardiopatía. XXI Congreso Nacional de Cardiología. Guadalajara. Arch Inst Cardiol Méx 1999; 5 (Supl 1): 1-19.
Van Ommen GJB, Breuning M H, Road AK: FISH in genome research and molecular diagnostic. Current Opinion in Genetics and Development. 1995; 5: 304-308.
Lu JH, Chung MY, Hwang B, Chien HP: Prevalence and parental origin in tetralogy of Fallot associated with chromosome 22 q11 microdeletion. Pediatrics 1999; 104: 87-90.
McCandless Shawn E, Scott Jennifer A: Deletion 22q11, a newly recognized cause of Behavioral and Psychiatric Disorders. Arch Pediatr Adolesc Med 1998; 152: 481-484.
Moss EM, Batshaw ML, Soto CE, Gerdes M, McDonald-McGinn D: Psychoeducational profile of the 22q11 microdeletion: A complex pattern. J Pediatr 1999; 134: 193-198.
Krahn LE, Maragarone D, Michels V: Childhood onset Schizophrenia Associated with Parkinsonism in a patient with a microdeletion of chromosome 22. May Clin Proc 1998; 73 (10): 9565-9569.
Sullivan K, Jawad AF, Randall P, Driscoll DA, Emanuel BS: Lack of correlation between impaired T cell production, immunodeficiency and other phenotypic features in chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome / Velocardiofacial Syndrome). Cl Immunol and Inmunopathol 1998; 86:141-146.
Digilio MC, Marino B, Giannotti A, Dallapiccola B: Conotruncal heart defect/microphthalmia syndrome: delineation of an autosomal recessive syndrome. J Med Genet 1997; 34: 927-929.
Sabry MA, Zaki M, Hassan SJ, Abdul, Ramadan DG: Kenny-Caffey Syndrome is part of the CATCH 22 haploinsufficiency Cluster. J Med Genet 1998; 35: 31-36.
Goldmuntz E, Clark B, Mitchell L, Jawad AF, Cuneo BF, Reed L: Frequency of 22q11 Deletions in Patients with Conotruncal Defects. J Am Coll Cardiol 1998; 32(2): 492-498.
Bonnet D, Cormier Daire V, Kachaner J: Microsatellite DNA markers detects 95% of chromosome 22q11 deletions. Am J Med Genet 1997; 68: 2,182-4.
Calvimontes G, Ramírez S, Calderón J, Rivera L, Miranda I, Zabal C, Buendía A: Atresia pulmonar con comunicación interventricular, resultados quirúrgicos. XXI Congreso Nacional de Cardiología. Guadalajara. Arch Inst Cardiol Méx 1999; 5 (Supl1): 1-5.